Literature DB >> 15229162

Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients.

Joseph T Chang1, Fen-Hwa Wong, Chun-Ta Liao, I-How Chen, Hung-Ming Wang, Ann-Joy Cheng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229162     DOI: 10.1373/clinchem.2003.026666

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

Review 1.  A systematic review of humoral immune responses against tumor antigens.

Authors:  Miriam Reuschenbach; Magnus von Knebel Doeberitz; Nicolas Wentzensen
Journal:  Cancer Immunol Immunother       Date:  2009-06-28       Impact factor: 6.968

2.  Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.

Authors:  Bozena Dobrzycka; Beata Mackowiak-Matejczyk; Katarzyna Maria Terlikowska; Bozena Kulesza-Bronczyk; Maciej Kinalski; Slawomir Jerzy Terlikowski
Journal:  Tumour Biol       Date:  2015-01-12

3.  Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.

Authors:  Chung-Guei Huang; Li-Ang Lee; Chun-Ta Liao; Tzu-Chen Yen; Shu-Li Yang; Yi-Chun Liu; Jung-Chin Li; Yu-Nong Gong; Chung-Jan Kang; Shiang-Fu Huang; Ku-Hao Fang; Kai-Ping Chang; Li-Yu Lee; Chuen Hsueh; Shin-Ru Shih; Kuo-Chien Tsao
Journal:  Oncotarget       Date:  2017-05-23

4.  Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients.

Authors:  Ratchada Cressey; Saranya Pimpa; Busyamas Chewaskulyong; Nirush Lertprasertsuke; Somchareon Saeteng; Chatchai Tayapiwatana; Watchara Kasinrerk
Journal:  BMC Biotechnol       Date:  2008-02-20       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.